CXCL9 released by tumor cells can regulate the enrichment of NK cell subset that expresses tumor necrosis factor-related apoptosis-in-ducing ligand (TRAIL+NK cell) to tumor tissues. The gene discussed is CXCL9; the disease is neoplasm.